AIMC Topic: Drug Discovery

Clear Filters Showing 741 to 750 of 1689 articles

A Novel Method for Inferring Chemical Compounds With Prescribed Topological Substructures Based on Integer Programming.

IEEE/ACM transactions on computational biology and bioinformatics
Drug discovery is one of the major goals of computational biology and bioinformatics. A novel framework has recently been proposed for the design of chemical graphs using both artificial neural networks (ANNs) and mixed integer linear programming (MI...

Structural Analysis and Prediction of Hematotoxicity Using Deep Learning Approaches.

Journal of chemical information and modeling
Hematotoxicity has been becoming a serious but overlooked toxicity in drug discovery. However, only a few models have been reported for the prediction of hematotoxicity. In this study, we constructed a high-quality dataset comprising 759 hematotoxic...

Exposing the Limitations of Molecular Machine Learning with Activity Cliffs.

Journal of chemical information and modeling
Machine learning has become a crucial tool in drug discovery and chemistry at large, , to predict molecular properties, such as bioactivity, with high accuracy. However, activity cliffs─pairs of molecules that are highly similar in their structure bu...

Exploration of Chemical Space Guided by PixelCNN for Fragment-Based De Novo Drug Discovery.

Journal of chemical information and modeling
We report a novel framework for achieving fragment-based molecular design using pixel convolutional neural network (PixelCNN) combined with the simplified molecular input line entry system (SMILES) as molecular representation. While a widely used rec...

Antibiotic discovery in the artificial intelligence era.

Annals of the New York Academy of Sciences
As the global burden of antibiotic resistance continues to grow, creative approaches to antibiotic discovery are needed to accelerate the development of novel medicines. A rapidly progressing computational revolution-artificial intelligence-offers an...

Few-Shot Learning for Low-Data Drug Discovery.

Journal of chemical information and modeling
The discovery of new hits through ligand-based virtual screening in drug discovery is essentially a low-data problem, as data acquisition is both difficult and expensive. The requirement for large amounts of training data hinders the application of c...

Deep graph level anomaly detection with contrastive learning.

Scientific reports
Graph level anomaly detection (GLAD) aims to spot anomalous graphs that structure pattern and feature information are different from most normal graphs in a graph set, which is rarely studied by other researchers but has significant application value...

ToxMVA: An end-to-end multi-view deep autoencoder method for protein toxicity prediction.

Computers in biology and medicine
Effectively predicting protein toxicity plays an essential step in the early stage of protein-based drug discovery, which is of great help to speed up novel drug screening and reduce costs. Recently, several relevant datasets have been designed, and ...

Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor.

Nature communications
The retrieval of hit/lead compounds with novel scaffolds during early drug development is an important but challenging task. Various generative models have been proposed to create drug-like molecules. However, the capacity of these generative models ...

Multimodal multi-task deep neural network framework for kinase-target prediction.

Molecular diversity
Kinase plays a significant role in various disease signaling pathways. Due to the highly conserved sequence of kinase family members, understanding the selectivity profile of kinase inhibitors remains a priority for drug discovery. Previous methods f...